C
CurvaFix
Helping those who have suffered pelvic fractures heal in a faster and more successful manner
About CurvaFix
CurvaFix, Inc. is a privately held medical device company, founded in 2013, that is addressing complex challenges in orthopedic trauma surgery. The company’s genesis stems from an idea by Dr. Robert Meek, a Clinical Professor Emeritus and the former Division Head of Orthopaedic Trauma at the University of British Columbia. Dr. Meek identified a critical unmet need for improved fixation methods for fractures in curved bones, particularly the pelvis, which existing straight screws and bone plates often inadequately address.
Read full description
The company's core product is the CurvaFix® Intramedullary (IM) Implant, the first major innovation in pelvic trauma technology in three decades. This implant is uniquely designed to be flexible during a minimally invasive surgical procedure, allowing it to navigate the natural curvature of a patient's bone. Once correctly positioned over a steerable guidewire, the surgeon locks the implant, causing it to become rigid and provide strong, stable fixation. This approach is designed to fill the intramedullary space within the bone, distributing force more evenly and reducing the risk of implant pullout. The procedure can often be completed in as little as 20 to 25 minutes.
CurvaFix operates in the orthopedic trauma market, estimated to be over $1.1 billion globally, serving orthopedic trauma surgeons. Its clients are hospitals and surgical centers treating patients with pelvic fractures resulting from high-impact trauma (like car accidents) and fragility fractures common in geriatric patients. The company has received multiple 510(k) clearances from the U.S. Food and Drug Administration (FDA) for its devices, starting with the CurvaFix Rodscrew in 2019 and followed by clearances for its IM Implants. The implants are available in various diameters (7.5mm and 9.5mm) and lengths to accommodate different patient anatomies. To date, CurvaFix has raised approximately $60 million in funding over several rounds, including a significant $39 million Series C round in July 2023, led by MVM Partners. These funds are allocated to the nationwide commercial launch and expansion of its IM Implant system.
The company is headquartered in Bellevue, Washington. In July 2023, founder Steve Dimmer transitioned from CEO to a strategic advisory role, and Mark Foster, an executive with extensive experience in the medical device industry, including as former president and CEO of Trice Medical, was appointed as the new CEO. Keywords: orthopedic trauma, pelvic fracture fixation, intramedullary implant, medical device, surgical technology, curved bone repair, minimally invasive surgery, fragility fractures, acetabular fractures, orthopedic surgery, bone fixation, trauma care, medical implant, CurvaFix IM Implant, Robert Meek, Steve Dimmer, Mark Foster, MVM Partners, Sectoral Asset Management, pelvic trauma.
At a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Bellevue, United States
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 88.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, medical implants, Surgery, Spinout, Orthopedic, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning CurvaFix.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jul 2023 | $39M | $156M | Sectoral Asset Management · MVM Life Science Partners | ↗ |
| CONVERTIBLEOther financing | Jun 2023 | $3M | — | SWAN Venture Fund | — |
Growth signals
Latest recorded traffic for CurvaFix is 3.1K monthly website visits, up 29.2% over the last three months. CurvaFix's team grew 5.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
SWAN Venture Fund
Tech Coast Angels
Sectoral Asset Management
Delta Dental of Washington
Series B and later1 investor entered at this stage
MVM Life Science Partners
Other known investors1 additional known investor
The University of British Columbia
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CurvaFix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CurvaFix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






